The document summarizes the results and updates from the NHS AAA Screening Programme. Some key points:
- Almost 1.3 million men were invited for screening, with an uptake of 79.5%
- Nearly 13,000 abdominal aortic aneurysms (AAA) larger than 3cm were detected, with a prevalence of 1.3%
- Options to extend surveillance intervals to biennially were presented, which could result in cost savings of over £600,000 per invited cohort.
- Evidence was presented on the risk of AAA progression in men with subaneurysmal aortas between 2.6-2.9cm, supporting potential rescreening of these men after 5 years.
Localized Prostate Cancer in Puerto Ricoflasco_org
This document summarizes localized prostate cancer screening and treatment options in Puerto Rico. It discusses screening guidelines and biomarkers like PSA, PCA3, and multiparametric MRI. Treatment options covered include active surveillance, surgery (open, robotic, cryotherapy), and radiation therapy (brachytherapy, external beam). Robotic prostatectomy results in less blood loss and shorter catheter time compared to open surgery. Adjuvant radiation after prostatectomy may improve outcomes for men with adverse features like positive margins or extraprostatic extension.
Empowering GPs to work collectively to improve patient care - Dr Richard Healicon and Mel Varvel
Free GRASP tools for GPs for atrial fibrillation, heart failure and COPD
Presentation from the Health and Care Innovation Expo 2014
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...sarahsteklov
A briefing note on cervical cancer screening practices in the Gwassi Division, Suba District, Nyanza Province, Kenya. Includes WHO guidelines, a pilot study in a neighboring region and interview and survey data from the community.
The document discusses the Vascular Quality Initiative (VSGNE), a regional collaborative focused on improving vascular care quality through data collection and analysis. Key points:
- VSGNE was founded in 2001 with 9 hospitals and has grown to include 30 hospitals. It collects detailed clinical data on over 33,000 procedures to track outcomes and drive quality improvement.
- Semi-annual meetings bring surgeons together to discuss benchmarked results, stimulate cooperative projects, and overcome insular practices. Regional analysis of variations in processes and outcomes identifies areas for improvement.
- Examples of quality improvements include increased pre-op statin use, reduced restenosis rates through increased carotid patching, and more accurate cardiac risk prediction models - all leading
Critical Care Research: Connection to PracticeAllina Health
1) The document discusses a critical care research program at Abbott Northwestern Hospital with the goals of conducting studies to improve patient outcomes, enhance quality of care, and reduce costs.
2) The program involves intensivists, hospitalists, and other clinical specialties conducting studies and presenting findings to improve practice.
3) Several ongoing studies are summarized that examine issues like postoperative monitoring, pulmonary ultrasound scoring, infection risks, and outcomes after procedures.
Implementing American Heart Association Practice Standards for Inpatient ECG ...Allina Health
Implementing American Heart Association Practice Standards for Inpatient ECG Monitoring: An Interventional Study at Abbott Northwestern Hospital presented by Kristin Sandau, PhD, RN
This document discusses technology assessment, outcomes research, and economic analyses in healthcare. It provides background on rising healthcare costs in the US without clear improvements in health outcomes compared to other countries. The rationale for assessing new technologies and their impact is described. Key aspects of technology assessment are outlined, including technical efficacy, diagnostic accuracy, diagnostic impact, therapeutic impact, patient outcomes, and societal outcomes. Challenges with randomized controlled trials in assessing technologies are reviewed. The National Lung Screening Trial is presented as an example. Finally, computed tomography for appendicitis is analyzed as a hypothetical example of how modeling could be used to assess a technology when a randomized trial may not be feasible.
Challenges and improvements in diagnostic services across seven day services NHS Improving Quality
Prof Erika Denton, National Clinical Director for Diagnostics. Slides from Erika's presentation at the 7 Day services events in West Midlands 11th June and East Midlands 12th June, 2014.
Localized Prostate Cancer in Puerto Ricoflasco_org
This document summarizes localized prostate cancer screening and treatment options in Puerto Rico. It discusses screening guidelines and biomarkers like PSA, PCA3, and multiparametric MRI. Treatment options covered include active surveillance, surgery (open, robotic, cryotherapy), and radiation therapy (brachytherapy, external beam). Robotic prostatectomy results in less blood loss and shorter catheter time compared to open surgery. Adjuvant radiation after prostatectomy may improve outcomes for men with adverse features like positive margins or extraprostatic extension.
Empowering GPs to work collectively to improve patient care - Dr Richard Healicon and Mel Varvel
Free GRASP tools for GPs for atrial fibrillation, heart failure and COPD
Presentation from the Health and Care Innovation Expo 2014
Briefing Note: Cervical Cancer Screening in the Gwassi Division, Suba Distric...sarahsteklov
A briefing note on cervical cancer screening practices in the Gwassi Division, Suba District, Nyanza Province, Kenya. Includes WHO guidelines, a pilot study in a neighboring region and interview and survey data from the community.
The document discusses the Vascular Quality Initiative (VSGNE), a regional collaborative focused on improving vascular care quality through data collection and analysis. Key points:
- VSGNE was founded in 2001 with 9 hospitals and has grown to include 30 hospitals. It collects detailed clinical data on over 33,000 procedures to track outcomes and drive quality improvement.
- Semi-annual meetings bring surgeons together to discuss benchmarked results, stimulate cooperative projects, and overcome insular practices. Regional analysis of variations in processes and outcomes identifies areas for improvement.
- Examples of quality improvements include increased pre-op statin use, reduced restenosis rates through increased carotid patching, and more accurate cardiac risk prediction models - all leading
Critical Care Research: Connection to PracticeAllina Health
1) The document discusses a critical care research program at Abbott Northwestern Hospital with the goals of conducting studies to improve patient outcomes, enhance quality of care, and reduce costs.
2) The program involves intensivists, hospitalists, and other clinical specialties conducting studies and presenting findings to improve practice.
3) Several ongoing studies are summarized that examine issues like postoperative monitoring, pulmonary ultrasound scoring, infection risks, and outcomes after procedures.
Implementing American Heart Association Practice Standards for Inpatient ECG ...Allina Health
Implementing American Heart Association Practice Standards for Inpatient ECG Monitoring: An Interventional Study at Abbott Northwestern Hospital presented by Kristin Sandau, PhD, RN
This document discusses technology assessment, outcomes research, and economic analyses in healthcare. It provides background on rising healthcare costs in the US without clear improvements in health outcomes compared to other countries. The rationale for assessing new technologies and their impact is described. Key aspects of technology assessment are outlined, including technical efficacy, diagnostic accuracy, diagnostic impact, therapeutic impact, patient outcomes, and societal outcomes. Challenges with randomized controlled trials in assessing technologies are reviewed. The National Lung Screening Trial is presented as an example. Finally, computed tomography for appendicitis is analyzed as a hypothetical example of how modeling could be used to assess a technology when a randomized trial may not be feasible.
Challenges and improvements in diagnostic services across seven day services NHS Improving Quality
Prof Erika Denton, National Clinical Director for Diagnostics. Slides from Erika's presentation at the 7 Day services events in West Midlands 11th June and East Midlands 12th June, 2014.
Service Improvement for Radiologists
a signposting document summarising service improvement methodology and benefits
Success factors - general
Success factors - computerised tomography
Technology Assessment, Outcomes Research and Economic Analysesevadew1
This document discusses technology assessment, outcomes research, and economic analyses in healthcare. It provides background on rising healthcare costs in the US and outlines a hierarchy for assessing new medical technologies from technical efficacy to patient and societal outcomes. Randomized controlled trials are described as the gold standard but limitations are noted. Alternative study designs like modeling and assessing intermediate outcomes are proposed when RCTs are not feasible. The document uses CT for appendicitis as an example to work through initial steps in outcomes research. It also discusses limitations and alternative outcomes like assessing the therapeutic value of diagnostic tests.
This document summarizes an assessment of data sources and quality used in South Africa's District Health Barometer. It finds that census and vital statistics data are generally adequate, while population surveys, health records, service records, and resource records are only present but not adequate. Health records in particular have problems of being burdensome, incomplete, of poor quality, and having inadequate staffing. The document reviews challenges with health data management and discusses specific issues with HIV prevalence data sources and vital statistics reporting.
This document discusses quality assurance indicators for radiation oncology facilities and treatment. It outlines general, medical physics, treatment accuracy and complexity, and patient satisfaction indicators. It provides details on staffing records, recommendations, treatment planning, equipment quality assurance, treatment delivery, acute and late effects for different treatment sites, and results of patient satisfaction surveys. Overall it evaluates the performance and quality of a radiation oncology facility based on various quality indicators.
Revolutionizing Renal Care With Predictive Analytics for CKDViewics
Chronic Kidney Disease (CKD) is a common and growing condition, affecting about half of the Medicare population and of diabetics. In the United States, the lifetime risk of CKD for 30-year-olds is now greater than half, and the prevalence of CKD is projected to rise significantly over the next 15 years.
Current methods of predicting which CKD patients will progress to renal failure and require dialysis or transplant have low accuracy rates, causing great anxiety and suboptimal care. Without accurate risk prediction, many patients are over-treated, effectively wasting limited resources and negatively impacting outcomes. Conversely, other patients may receive inadequate treatment, restricting options to only the most costly and least desirable interventions.
Watch this on-demand webinar with Dr. Navdeep Tangri, developer of the Kidney Failure Risk Equation, which revolutionizes the way CKD patients are managed by leveraging laboratory data to accurately predict the risk of kidney failure in patients with CKD.
You’ll learn:
• How CKD is burdening our healthcare system, and the need for better care management tools
• How the Kidney Failure Risk Equation was researched, developed, and validated
• How Viewics is implementing CKD predictive analytics to automatically deliver risk information to clinicians and issue customized, educational reports to patients and clinicians
Damian o'connell - Transformation of the global clinical trials footprint in ...ipposi
The document summarizes the rationale for transforming a big pharmaceutical company's global clinical trials footprint. It discusses:
1) Increasing drug development costs and the need for more trials and patients to get approvals, driving the need for changes.
2) An analysis of baseline clinical trials data across many countries that found cycle times exceeding benchmarks and inhibiting bringing drugs to market faster.
3) A process for selecting core and non-core countries for clinical trials based on quality, population size, performance metrics, and a quantitative and qualitative analysis.
4) The resulting new clinical trials footprint, designating some European, Asian, and other countries and regions as core, with others as non-core.
IVR Clinical Concepts (www.ivrcc.com) is a technology company delivering patient registration, randomization and trial supply management (RTSM) and ePRO/eCOA via IVR/IMR/IWR for the electronic collection of patient/caregiver reported outcomes. The IVRCC System collects data as eSource and communicates in real-time seamlessly exchanging data with other eClinical Systems including OmniComm TrialMaster, Medidata RAVE and other EDC and CTM Systems. Much of the primary and secondary endpoint data for CNS, Behavioral Disorders, GI Disorders, and other therapeutics areas is collected from patient, caregiver and interviewer (Rater) reported outcomes. The overwhelming evidence is that collection of ePRO/eCOA data by electronic means vs. paper, combined with patient and site engagement reminders, results in more contemporaneous, complete, compliant and accurate data which is able to be accessed by study stakeholders in real-time.
AAA screening national programme update September 2019: Lisa SummersPHEScreening
This document provides a national update on the AAA screening programme in the UK. It discusses updates to clinical leads, screening figures, key performance indicators, standards and guidance, IT systems, equipment evaluation, rationale for modifying surveillance intervals, and initiatives across the four nations and to address inequalities in screening.
I DON'T need ultrasound monitoring on the ICUAdrian Wong
Taking the con side for this debate at the International Fluid Academy Day - Antwerp, Belgium.
Hopefully it provides some of the limitations of US on the ICU - focussing mostly on lack of governance and system
Dissemination of community scoore card to districtsCissy Namuzimbi
The community score card approach was used to assess the quality of HIV/AIDS services in 3 districts of Uganda. Key findings included poor ratings for male circumcision and adolescent HIV care due to cultural beliefs and lack of privacy. ART access received fair-good ratings but with stockouts and stigma as issues. Family planning services faced challenges of negative beliefs and domestic violence. Staffing gaps exceeded 50% at some health centers. Recommendations focused on increasing staffing, addressing stockouts, improving community sensitization and awareness of patient rights.
Advanced Lab Analytics for Patient Blood Management ProgramsViewics
Reports indicate that 30 – 70% of blood transfusions are inappropriate. Inappropriate blood transfusions put patients at increased risk of post-surgical infections, multi-system organ failure, longer hospital stays, and higher mortality rates. The transfusion guidelines most clinicians learned in their training are now outdated. As such, blood transfusion practices vary widely, and overutilization remains a major quality and cost problem.
Patient Blood Management (PBM) programs are designed to optimize the use of transfusions through a team-based approach, evidence-based guidelines, and algorithms that together guide decisions regarding specifically which patients and clinical procedures warrant blood products, and how much to transfuse. PBM programs have been quite successful in improving patient morbidity and mortality outcomes and generating millions of dollars in savings for hospitals.
Laboratory analytics can be an effective means of instituting restrictive transfusion programs, and advanced lab analytics can be critical in implementing PBM programs, as lab testing and tracking blood usage is central to decision making, changing behavior, and improving performance.
Watch a presentation by Dr. Eleanor Herriman, Chief Medical Informatics Officer at Viewics. She unveils a new suite of advanced analytics tools that support PBS and other restrictive blood management programs, enabling health systems to better leverage their valuable lab medicine assets and fully integrate this key service line into these programs.
You’ll learn:
• How inappropriate blood transfusions are burdening our healthcare system, and the need for better utilization management tools
• New guidelines restricting red blood cell transfusions
• The role of advanced lab analytics in PBM programs
• How Viewics is leveraging advanced lab analytics to help health systems more easily and cost-effectively implement PBM programs
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...eram sid
This document discusses pulse oximetry screening for critical congenital heart defects. It provides background on studies showing pulse oximetry can detect many cases of critical CHD before clinical symptoms appear. While early studies had small sample sizes, later studies of over 100,000 babies screened in the UK found a sensitivity of 83.6% and low false positive rate of 0.3%. The document examines different screening protocols and their effectiveness. It concludes that pulse oximetry screening is a feasible, acceptable, and cost-effective approach to reducing the diagnostic gap for critical CHD.
This document provides guidelines for performing mid-trimester fetal ultrasound scans from the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). It discusses the purpose of the scans, who should perform them, necessary equipment, what should be included in reports, safety considerations, assessing fetal well-being and biometry, examining fetal anatomy, and evaluating the cervix, uterus and adnexa. The guidelines emphasize providing accurate information to optimize care, while minimizing risk, and include a sample reporting form.
Best Practices for a Data-driven Approach to Test UtilizationViewics
Would you like to learn how data-driven interventions can improve laboratory test utilization in your organization? Would you like to hear about the impact that leading hospitals/health systems and managed care organizations have made through these interventions?
If so, you might be interested in this presentation by utilization management expert Dr. Michael Astion, Medical Director at the Department of Laboratories at Seattle Children’s Hospital and Clinical Professor of Laboratory Medicine at the University of Washington.
In this presentation, Dr. Astion discusses the current state of the misuse of laboratory testing in the United States and some of the interventions that are being implemented to improve it. He covers a number of common areas of unnecessary testing — from pure abuse to tests that could be useful but are ordered inappropriately.
You'll learn about:
• Two areas of laboratory testing where misordering of tests occur frequently
• Three interventions to improve the value of testing for patients
• The role of genetic counselors and other laboratory professionals in improving lab test ordering
• The national endeavor known as PLUGS, the Pediatric Laboratory Utilization Guidance Service
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
ADA 617-P_Improving DR screening is a complex challengeJiani Hu
Most diabetes patients (71%) did not receive DR screening. Screening capacity was the major limitation, as screening all diabetes patients would use 99% of available visits. In-clinic eye support doubled screening rates from 22% to 48% and decreased screens done in the ophthalmology clinic from 96% to 45%. Barriers to screening included lack of continuity care, missed appointments, low referral rates, and mental health diagnoses other than depression. Comprehensive DR screening requires dramatically increasing capacity for screening and treatment, engaging more patients in regular diabetes care, developing tracking systems for missed appointments, and considering alternative screening methods.
The National Cancer Strategy in Qatar 2011-2016 aims to establish a comprehensive national cancer control program. It was developed in response to the increasing cancer burden in Qatar due to risk factors like smoking and obesity. The strategy outlines recommendations across the cancer continuum from prevention to treatment to palliative care. It also establishes a governance structure and implementation plan. Formal reviews will be conducted in 2013 and 2016 to evaluate progress and refresh the strategy.
- An estimated 1300 new cases of cervical cancer were diagnosed in Canada in 2011, with about 350 deaths. The incidence and mortality of cervical cancer have substantially decreased in the past 50 years due to screening.
- Screening for cervical cancer using the Pap test detects precursor lesions, allowing earlier treatment and reducing incidence of invasive disease and death from cervical cancer.
- This guideline provides updated recommendations for cervical cancer screening in Canada based on new evidence about epidemiology and diagnosis of cervical cancer. It recommends screening with Pap tests every 3 years for women aged 30-69, and discusses potential benefits and harms of screening for other age groups.
This document describes an obstetric enhanced recovery program aimed at reducing hospital stay after cesarean sections without increasing complications. The program provides evidence-based care including early mobilization, catheter removal within 6 hours, and discharge within 24-36 hours. An audit of 30 cases found some improvements in identifying eligible women but also areas for further improvement such as completing discharge prescriptions in the operating theater and documenting reasons for delays in the enhanced recovery pathway. Recommendations include improving these areas as well as staff engagement to fully implement the program.
The document summarizes results from the National Abdominal Aortic Aneurysm Screening Programme in England. Over 1.5 million men were screened, with over 18,000 large AAAs detected. Nearly 14,000 men are in surveillance and over 3,400 men have been treated. The programme is optimizing to reduce surveillance intervals and improve uptake. Research is ongoing on quality of life for men in surveillance and outcomes for those with subaneurysmal aortas. Draft NICE guidelines recommend screening and surveillance protocols. The future of the programme involves monitoring these changes and improving care for men identified.
Lisa Summers provided a national update on the NHS AAA Screening Programme. Key points included:
- Coverage and uptake rates for 2016/17 were 79.0% and 79.3% respectively.
- The programme is optimizing surveillance intervals and introducing an inequalities initiative to improve uptake by 10%.
- Further research is being done on men with subaneurysmal aortas to understand potential harms of surveillance.
- Issues raised from local programmes included improving GP endorsement of invitation letters and researching men who decline or do not attend screening.
Morag Armer then discussed emerging themes from QA visits, including governance, infrastructure, cohort and uptake data, test accuracy, and
Service Improvement for Radiologists
a signposting document summarising service improvement methodology and benefits
Success factors - general
Success factors - computerised tomography
Technology Assessment, Outcomes Research and Economic Analysesevadew1
This document discusses technology assessment, outcomes research, and economic analyses in healthcare. It provides background on rising healthcare costs in the US and outlines a hierarchy for assessing new medical technologies from technical efficacy to patient and societal outcomes. Randomized controlled trials are described as the gold standard but limitations are noted. Alternative study designs like modeling and assessing intermediate outcomes are proposed when RCTs are not feasible. The document uses CT for appendicitis as an example to work through initial steps in outcomes research. It also discusses limitations and alternative outcomes like assessing the therapeutic value of diagnostic tests.
This document summarizes an assessment of data sources and quality used in South Africa's District Health Barometer. It finds that census and vital statistics data are generally adequate, while population surveys, health records, service records, and resource records are only present but not adequate. Health records in particular have problems of being burdensome, incomplete, of poor quality, and having inadequate staffing. The document reviews challenges with health data management and discusses specific issues with HIV prevalence data sources and vital statistics reporting.
This document discusses quality assurance indicators for radiation oncology facilities and treatment. It outlines general, medical physics, treatment accuracy and complexity, and patient satisfaction indicators. It provides details on staffing records, recommendations, treatment planning, equipment quality assurance, treatment delivery, acute and late effects for different treatment sites, and results of patient satisfaction surveys. Overall it evaluates the performance and quality of a radiation oncology facility based on various quality indicators.
Revolutionizing Renal Care With Predictive Analytics for CKDViewics
Chronic Kidney Disease (CKD) is a common and growing condition, affecting about half of the Medicare population and of diabetics. In the United States, the lifetime risk of CKD for 30-year-olds is now greater than half, and the prevalence of CKD is projected to rise significantly over the next 15 years.
Current methods of predicting which CKD patients will progress to renal failure and require dialysis or transplant have low accuracy rates, causing great anxiety and suboptimal care. Without accurate risk prediction, many patients are over-treated, effectively wasting limited resources and negatively impacting outcomes. Conversely, other patients may receive inadequate treatment, restricting options to only the most costly and least desirable interventions.
Watch this on-demand webinar with Dr. Navdeep Tangri, developer of the Kidney Failure Risk Equation, which revolutionizes the way CKD patients are managed by leveraging laboratory data to accurately predict the risk of kidney failure in patients with CKD.
You’ll learn:
• How CKD is burdening our healthcare system, and the need for better care management tools
• How the Kidney Failure Risk Equation was researched, developed, and validated
• How Viewics is implementing CKD predictive analytics to automatically deliver risk information to clinicians and issue customized, educational reports to patients and clinicians
Damian o'connell - Transformation of the global clinical trials footprint in ...ipposi
The document summarizes the rationale for transforming a big pharmaceutical company's global clinical trials footprint. It discusses:
1) Increasing drug development costs and the need for more trials and patients to get approvals, driving the need for changes.
2) An analysis of baseline clinical trials data across many countries that found cycle times exceeding benchmarks and inhibiting bringing drugs to market faster.
3) A process for selecting core and non-core countries for clinical trials based on quality, population size, performance metrics, and a quantitative and qualitative analysis.
4) The resulting new clinical trials footprint, designating some European, Asian, and other countries and regions as core, with others as non-core.
IVR Clinical Concepts (www.ivrcc.com) is a technology company delivering patient registration, randomization and trial supply management (RTSM) and ePRO/eCOA via IVR/IMR/IWR for the electronic collection of patient/caregiver reported outcomes. The IVRCC System collects data as eSource and communicates in real-time seamlessly exchanging data with other eClinical Systems including OmniComm TrialMaster, Medidata RAVE and other EDC and CTM Systems. Much of the primary and secondary endpoint data for CNS, Behavioral Disorders, GI Disorders, and other therapeutics areas is collected from patient, caregiver and interviewer (Rater) reported outcomes. The overwhelming evidence is that collection of ePRO/eCOA data by electronic means vs. paper, combined with patient and site engagement reminders, results in more contemporaneous, complete, compliant and accurate data which is able to be accessed by study stakeholders in real-time.
AAA screening national programme update September 2019: Lisa SummersPHEScreening
This document provides a national update on the AAA screening programme in the UK. It discusses updates to clinical leads, screening figures, key performance indicators, standards and guidance, IT systems, equipment evaluation, rationale for modifying surveillance intervals, and initiatives across the four nations and to address inequalities in screening.
I DON'T need ultrasound monitoring on the ICUAdrian Wong
Taking the con side for this debate at the International Fluid Academy Day - Antwerp, Belgium.
Hopefully it provides some of the limitations of US on the ICU - focussing mostly on lack of governance and system
Dissemination of community scoore card to districtsCissy Namuzimbi
The community score card approach was used to assess the quality of HIV/AIDS services in 3 districts of Uganda. Key findings included poor ratings for male circumcision and adolescent HIV care due to cultural beliefs and lack of privacy. ART access received fair-good ratings but with stockouts and stigma as issues. Family planning services faced challenges of negative beliefs and domestic violence. Staffing gaps exceeded 50% at some health centers. Recommendations focused on increasing staffing, addressing stockouts, improving community sensitization and awareness of patient rights.
Advanced Lab Analytics for Patient Blood Management ProgramsViewics
Reports indicate that 30 – 70% of blood transfusions are inappropriate. Inappropriate blood transfusions put patients at increased risk of post-surgical infections, multi-system organ failure, longer hospital stays, and higher mortality rates. The transfusion guidelines most clinicians learned in their training are now outdated. As such, blood transfusion practices vary widely, and overutilization remains a major quality and cost problem.
Patient Blood Management (PBM) programs are designed to optimize the use of transfusions through a team-based approach, evidence-based guidelines, and algorithms that together guide decisions regarding specifically which patients and clinical procedures warrant blood products, and how much to transfuse. PBM programs have been quite successful in improving patient morbidity and mortality outcomes and generating millions of dollars in savings for hospitals.
Laboratory analytics can be an effective means of instituting restrictive transfusion programs, and advanced lab analytics can be critical in implementing PBM programs, as lab testing and tracking blood usage is central to decision making, changing behavior, and improving performance.
Watch a presentation by Dr. Eleanor Herriman, Chief Medical Informatics Officer at Viewics. She unveils a new suite of advanced analytics tools that support PBS and other restrictive blood management programs, enabling health systems to better leverage their valuable lab medicine assets and fully integrate this key service line into these programs.
You’ll learn:
• How inappropriate blood transfusions are burdening our healthcare system, and the need for better utilization management tools
• New guidelines restricting red blood cell transfusions
• The role of advanced lab analytics in PBM programs
• How Viewics is leveraging advanced lab analytics to help health systems more easily and cost-effectively implement PBM programs
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...eram sid
This document discusses pulse oximetry screening for critical congenital heart defects. It provides background on studies showing pulse oximetry can detect many cases of critical CHD before clinical symptoms appear. While early studies had small sample sizes, later studies of over 100,000 babies screened in the UK found a sensitivity of 83.6% and low false positive rate of 0.3%. The document examines different screening protocols and their effectiveness. It concludes that pulse oximetry screening is a feasible, acceptable, and cost-effective approach to reducing the diagnostic gap for critical CHD.
This document provides guidelines for performing mid-trimester fetal ultrasound scans from the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). It discusses the purpose of the scans, who should perform them, necessary equipment, what should be included in reports, safety considerations, assessing fetal well-being and biometry, examining fetal anatomy, and evaluating the cervix, uterus and adnexa. The guidelines emphasize providing accurate information to optimize care, while minimizing risk, and include a sample reporting form.
Best Practices for a Data-driven Approach to Test UtilizationViewics
Would you like to learn how data-driven interventions can improve laboratory test utilization in your organization? Would you like to hear about the impact that leading hospitals/health systems and managed care organizations have made through these interventions?
If so, you might be interested in this presentation by utilization management expert Dr. Michael Astion, Medical Director at the Department of Laboratories at Seattle Children’s Hospital and Clinical Professor of Laboratory Medicine at the University of Washington.
In this presentation, Dr. Astion discusses the current state of the misuse of laboratory testing in the United States and some of the interventions that are being implemented to improve it. He covers a number of common areas of unnecessary testing — from pure abuse to tests that could be useful but are ordered inappropriately.
You'll learn about:
• Two areas of laboratory testing where misordering of tests occur frequently
• Three interventions to improve the value of testing for patients
• The role of genetic counselors and other laboratory professionals in improving lab test ordering
• The national endeavor known as PLUGS, the Pediatric Laboratory Utilization Guidance Service
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
ADA 617-P_Improving DR screening is a complex challengeJiani Hu
Most diabetes patients (71%) did not receive DR screening. Screening capacity was the major limitation, as screening all diabetes patients would use 99% of available visits. In-clinic eye support doubled screening rates from 22% to 48% and decreased screens done in the ophthalmology clinic from 96% to 45%. Barriers to screening included lack of continuity care, missed appointments, low referral rates, and mental health diagnoses other than depression. Comprehensive DR screening requires dramatically increasing capacity for screening and treatment, engaging more patients in regular diabetes care, developing tracking systems for missed appointments, and considering alternative screening methods.
The National Cancer Strategy in Qatar 2011-2016 aims to establish a comprehensive national cancer control program. It was developed in response to the increasing cancer burden in Qatar due to risk factors like smoking and obesity. The strategy outlines recommendations across the cancer continuum from prevention to treatment to palliative care. It also establishes a governance structure and implementation plan. Formal reviews will be conducted in 2013 and 2016 to evaluate progress and refresh the strategy.
- An estimated 1300 new cases of cervical cancer were diagnosed in Canada in 2011, with about 350 deaths. The incidence and mortality of cervical cancer have substantially decreased in the past 50 years due to screening.
- Screening for cervical cancer using the Pap test detects precursor lesions, allowing earlier treatment and reducing incidence of invasive disease and death from cervical cancer.
- This guideline provides updated recommendations for cervical cancer screening in Canada based on new evidence about epidemiology and diagnosis of cervical cancer. It recommends screening with Pap tests every 3 years for women aged 30-69, and discusses potential benefits and harms of screening for other age groups.
This document describes an obstetric enhanced recovery program aimed at reducing hospital stay after cesarean sections without increasing complications. The program provides evidence-based care including early mobilization, catheter removal within 6 hours, and discharge within 24-36 hours. An audit of 30 cases found some improvements in identifying eligible women but also areas for further improvement such as completing discharge prescriptions in the operating theater and documenting reasons for delays in the enhanced recovery pathway. Recommendations include improving these areas as well as staff engagement to fully implement the program.
The document summarizes results from the National Abdominal Aortic Aneurysm Screening Programme in England. Over 1.5 million men were screened, with over 18,000 large AAAs detected. Nearly 14,000 men are in surveillance and over 3,400 men have been treated. The programme is optimizing to reduce surveillance intervals and improve uptake. Research is ongoing on quality of life for men in surveillance and outcomes for those with subaneurysmal aortas. Draft NICE guidelines recommend screening and surveillance protocols. The future of the programme involves monitoring these changes and improving care for men identified.
Lisa Summers provided a national update on the NHS AAA Screening Programme. Key points included:
- Coverage and uptake rates for 2016/17 were 79.0% and 79.3% respectively.
- The programme is optimizing surveillance intervals and introducing an inequalities initiative to improve uptake by 10%.
- Further research is being done on men with subaneurysmal aortas to understand potential harms of surveillance.
- Issues raised from local programmes included improving GP endorsement of invitation letters and researching men who decline or do not attend screening.
Morag Armer then discussed emerging themes from QA visits, including governance, infrastructure, cohort and uptake data, test accuracy, and
This document provides a summary of the national abdominal aortic aneurysm (AAA) screening programme in the UK, including key statistics and performance indicators for 2017/2018. It discusses several initiatives to improve the programme, such as adopting a new demographic data source, developing an inequalities toolkit, updating training resources, and establishing image quality standards. The document outlines plans to test a proposed 10-point image scoring system to help standardize the assessment of ultrasound image quality across the screening programme.
AAA London Network Event 27 Nov 2015 Jan Yates overview presentationPHEScreening
The document outlines an agenda for a network day for the Abdominal Aortic Aneurysm (AAA) Screening Programmes in London to improve quality through achieving pathway standards, sharing best practices, and establishing standardized reporting. Key topics to be discussed include the national and regional overviews of AAA screening, training requirements, and roles and responsibilities within screening teams. The overall aim is to support London programmes in safely and effectively screening their populations for AAAs.
The document outlines an agenda for a network day for the Abdominal Aortic Aneurysm (AAA) Screening Programmes in London to improve quality through achieving pathway standards, sharing best practices, and establishing standardized reporting. Key topics to be discussed include the national and regional overviews of AAA screening, training requirements, and roles and responsibilities within screening teams. The overall aim is to support London programmes in safely and effectively screening their populations for AAAs.
Professor Sue Hill OBE, Chief Scientific Officer for Englandrightcare
We are excited to introduce the NHS Atlas of Variation in Diagnostic Services, the latest publication in the series of impressive NHS Atlases, which have highlighted variation in the provision of healthcare services.
Diagnostic services are of great importance in the NHS because, when used correctly, they support or rule out potential diagnoses, and underpin the effective and efficient management of patient pathways.
Unwarranted variation in the rates of diagnostic testing is of the utmost relevance to individual patients with the over-use, as well as under-use, of diagnostic tests being potentially serious issues. For example, effective capacity planning in imaging services should enable improved patient access balanced against the need to avoid over-use of interventions that have the potential to cause harm, such as ionising radiation.
The document discusses barriers and solutions to adopting diagnostic technologies in healthcare. It provides examples of diagnostic technologies that have been successfully adopted in the UK, such as Coaguchek for INR testing and faecal calprotectin testing. Both faced initial barriers but were able to demonstrate benefits like improved patient outcomes and efficiency. The document outlines tips for implementing diagnostics, such as collecting baseline data, gaining stakeholder support, and clearly defining the patient pathway and expected impact. Overall it advocates that diagnostic technologies can help address gaps in healthcare if barriers are overcome and benefits are demonstrated.
AAA London Network Event 27 Nov 2015 Shelagh Murray vascular nurse speciali...PHEScreening
1) Vascular nurse specialists play an important role in abdominal aortic aneurysm (AAA) screening programs by providing basic information, assessing and supporting men who screen positive, and optimizing their health through lifestyle advice and monitoring.
2) A survey found that 28% of men had additional concerns after screening that were addressed through a nurse consultation, which 74% rated as excellent. Nurse consultations focus on medical history, risk factors, explaining the condition, and lifestyle advice.
3) Proper staffing and training of vascular nurse specialists is important for consistent high quality care within AAA screening programs.
This document outlines a real-world knowledge translation approach used in Alberta, Canada to facilitate evidence-informed decision making about robot-assisted surgery (RAS). It describes establishing committees to guide the re-evaluation of RAS, identifying current RAS procedures and gaps in evidence, developing strategies for data collection and a training/credentialing process, commissioning an economic analysis, and engaging patients. The overall goal is to ensure RAS technologies are implemented responsibly based on accurate local data and with oversight of costs, outcomes, and impacts on the health system and population health needs.
The document provides an overview of lung cancer screening and key events since the last UK National Screening Committee guidance on the topic in 2006 and 2007. It summarizes evidence from the National Lung Screening Trial showing a reduction in lung cancer mortality from low-dose CT screening. It also discusses the 2013 USPSTF recommendation based on this evidence and ongoing trials like NELSON. The PenTAG group at the University of Exeter will produce a health technology assessment on the clinical and cost-effectiveness of low-dose CT screening for lung cancer, incorporating results from the NELSON trial expected in late 2016, to inform future UK guidance.
7) local provider quality improvement ideasPHEScreening
This document summarizes the findings of a health equity audit of the Five Rivers abdominal aortic aneurysm (AAA) screening program. The audit found lower uptake of AAA screening in more deprived areas and among certain ethnic groups. It provides recommendations to improve uptake, including targeted outreach in areas of low uptake, improving data collection on ethnicity and disability, and conducting further equity audits.
Bea Brown | a locally tailored intervention to improve adherence to a clinica...Sax Institute
Bea Brown gave a presentation on her research for the Sax Institute at the University of Sydney for the School of Public Health's 2013 research presentation day.
National Comparative Audit of Lower Gastrointestinal Bleeding and the Use of ...Raimundas Lunevicius
This audit shows that there is no such thing as acute upper gastrointestinal (UGI) bleeding or acute lower gastrointestinal (LGI) bleeding. There is acute gastrointestinal (GI) bleeding, which predominantly is one of a few emergency gastroenterological conditions. In other words, a historic agreement between clinical directors to direct a patient presenting with hematemesis to gastroenterology ward & to direct another patient with PR bleed to Emergency General Surgery Ward is not quite logical, as PR bleeding is one of the signs of acute UGI as well as LGI bleeding.
The concentration of patients in one highly specialized unit for GI bleeding management WITHIN GASTROENTEROLOGY CENTRE is the second summary key point of this audit.
I do think that Gastroenterology Ward would be the best Ward to concentrate all patients presenting with signs of GI bleeding, for a mean patient presenting with this problem is:
(1) An elderly patient with significant comorbidities, often taking a so-called ‘blood thinner’ (aspirin, NSAIDs, and even steroids),
(2) Requiring limited volume blood transfusions - sometimes,
(3) Requiring radiological and endoscopic investigations within 24 hours / in a case of clinically significant bleeding,
(4) Not requiring urgent surgery in the absolute majority of the cases (5 emergency laparotomies in all four countries of the UK), and (5) Not having a clinical diagnosis on the day of discharge.
National Comparative Audit of Lower Gastrointestinal Bleeding and the Use of Blood: Findings and Interpretations
This audit examined practice and outcomes for 2,528 patients admitted with lower gastrointestinal bleeding (LGIB) across 143 UK hospitals. Key findings included inappropriate transfusion in 27% of patients, only 26% receiving endoscopy within 24 hours, and 49% having no investigations to identify the bleeding source. Performance was compared against 17 evidence-based standards, identifying opportunities for improvement particularly around medicines management and timely investigation. Interpretations highlighted the benefits of centralized specialized care for LGIB patients, including more consistent guideline-based care, regular auditing, teaching and lower costs through reduced variation.
Main Presentation UK Diagnostic Summit 2018Walt Whitman
The document summarizes a conference on maximizing diagnostic technology to tackle antimicrobial resistance (AMR) in the UK. It discusses the UK AMR Diagnostic Collaborative, which provides leadership and alignment across the diagnostic system. Key areas of focus for 2018-2019 include diagnostic stewardship, innovation, and understanding how health policy can support rapid diagnostic adoption. Upcoming milestones are surveys on blood culture and industry engagement to help accelerate diagnostic usage and solutions. Continued focus on diagnostics is crucial as the government refreshes its AMR strategy and action plan.
Providing actionable healthcare analytics at scale: Insights from the Nationa...Nuffield Trust
Christopher Boulton, Falls and Fragility Fracture Audit Programme Manager at the Royal College of Physicians and Rob Wakeman, Clinical Lead for Orthopaedic Surgery at the National Hip Fracture Database talk about what they have learned by analysing the national hip fracture database.
This document summarizes NHS England's approach to gathering patient experience and outcome data. It discusses various data collection methods, including national patient surveys, the Friends and Family Test, and Patient Reported Outcome Measures (PROMs). It notes that PROMs data shows patients report significant health improvements after surgeries and there is some variation in outcomes between hospitals. The document also outlines challenges in using this data and opportunities for the future, such as developing new PROMs for additional clinical areas and engaging patients more in collecting and using their own outcome data.
Colorectal screening evidence & colonoscopy screening guidelines Health Evidence™
Health Evidence hosted a 90 minute webinar examining colorectal cancer screening: benefits and harms, effective screening methods, and screening guidelines.Click here for access to the audio recording for this webinar: https://www.youtube.com/watch?v=JqOV-KHCBq8
Donna Fitzpatrick-Lewis, MSW, Senior Research Coordinator at the McMaster Evidence Review and Synthesis Centre and Dr. Maria Bacchus, Associate Professor of Medicine, Faculty of Medicine University of Calgary, and member of the Canadian Task Force on Preventive Health Care led the session. Donna presented the findings of the Synthesis Centre’s latest review and Dr. Bacchus presented findings from the Task Force’s latest guidelines:
Fitzpatrick-Lewis, D., Usman, A., Warren, R., Kenny, M., Rice, M., Bayer, A., Ciliska, D., Sherifali, D., Raina, P. Screening for colorectal cancer. Ottawa: Canadian Task Force on Preventive Health Care; 2015. Available: http://canadiantaskforce.ca/files/crc-screeningfinal2.pdf
Bacchus, C. M., Dunfield, L., Gorber, S. C., Holmes, N. M., Birtwhistle, R., Dickinson, J. A., Lewin, G., Singh, H., Klarenbach, S., Mai, V., Tonelli, M. (2016). Recommendations on screening for colorectal cancer in primary care. Canadian Medical Association Journal, cmaj-151125.
Among men and women, colorectal cancer is the second and third most common cause of cancer related death, respectively. Colorectal cancer screening guidelines, developed by the Canadian Task Force on Preventive Health Care, are based on a systematic review synthesizing evidence on the benefits and harms of screening, and the characteristics of effective screening tests. The guidelines, developed from the review, outline screening recommendations for adults aged 50 and older who are asymptomatic and not at high risk for colorectal cancer. This webinar provided a high level overview of the systematic review that informed these recommendations, followed by an overview of the recent Canadian screening guidelines.
This document discusses cancer prevention and screening. It provides statistics on the cancer burden worldwide and in India. The most common cancer sites in India are oral cavity, lungs, esophagus and stomach in males, and cervix, breast and oral cavity in females. Tobacco-related and cervical cancers account for a large number of new cases and deaths annually in India. Over 70% of cancer cases in India present at advanced stages. The document outlines various screening guidelines and programs for common cancers, including breast self-examination, clinical breast exam, visual inspection with acetic acid for cervical cancer, and screening recommendations for oral, prostate, lung and colorectal cancers. It discusses the objectives and methodology of community-based screening camps in India
Similar to AAA 2016 networking day final presentations (20)
Diabetic eye screening 1 April 2015 to 31 March 2016 data slide setMike Harris
This document provides charts and data to support the annual NHS Diabetic Eye Screening Programme report for the period of April 1, 2015 to March 31, 2016. It includes information on eligible patients, screening outcomes, referrals to eye hospitals, and notes on data quality for individual screening services. Definitions of key terms and codes for the 90 screening services across England are also provided.
Record of NHS Screening e-learning completionMike Harris
This document records Jonathan Waldheim's completion of various e-learning modules related to NHS screening programmes. It shows the dates that modules within different screening program topics were completed, including antenatal and newborn screening, sickle cell and thalassaemia screening, newborn blood spot screening, fetal anomaly scanning, nuchal translucency screening, sickle cell and thalassaemia laboratory techniques, newborn hearing screening, newborn and infant physical examination, abdominal aortic aneurysm screening, and 18-20 week fetal anomaly ultrasound scanning. The document provides details on over 50 individual e-learning modules and the dates they were completed from 2014 to 2017.
The document discusses guidelines for healthcare providers on communicating information to visually impaired patients effectively. It notes that as of August 2016, the Accessible Information Standard requires disabled patients receive information in accessible formats. It provides advice on coding patients' needs in medical records and asking about format preferences. It estimates that for a patient list of 12,000, around 72 will be blind or partially sighted and 600 will have uncorrected vision loss. The document answers frequent questions about alternative formats like email, braille, large print and audio, and estimates usage rates for each on a typical patient list. It recommends recording format preferences for individual patients.
Sarah Pond Norfolk AAA presentation diplomaMike Harris
This document discusses the qualifications and resources available for those seeking to become an Abdominal Aortic Aneurysm (AAA) screener through the Norfolk & Waveney AAA Screening Programme. Trainees can enroll in a Level 3 Diploma for Health Screeners which includes 13 mandatory units and AAA-specific pathway units covering the principles, ultrasound techniques, and performance of AAA screening. Resources provided include an e-learning system, portfolio for clinical experience and competency tracking, and support from an approved training center. The process for enrolling, completing units, and potential challenges are outlined.
This document provides an overview of assessing the Level 3 Diploma for Health Screeners qualification. It discusses the structure of units, learning outcomes, and assessment criteria. It explains Bloom's taxonomy and how it relates to unit structure. The document also outlines strategies for assessment, including using a range of methods, direct observation in the workplace, and ensuring assessments are valid, reliable, and meet awarding organization standards. Tips are provided for developing good assessment approaches, such as using up-to-date assessment plans and giving constructive feedback.
The document outlines the process for assessor qualification which includes 3 units covering understanding principles and practices of assessment, assessing occupational competence, and assessing vocational skills, knowledge and understanding. It describes the recognition of prior learning route which involves 3 key stages - a skills scan, telephone interview, and summative assessment. Candidates are allocated an assessor, complete a skills scan, and then have an assessment plan agreed upon to gather evidence to meet qualification requirements.
Cheryl Bott health screeners qualification presentationMike Harris
Cheryl Bott provides contact information for questions about health screeners qualifications. There are four awarding organizations that offer the new Health Screener qualification: Future Quals, Innovate Awarding, NOCN, and Pearson. Approved centers are given approval from awarding organizations to offer qualifications to learners. As approved centers, they are responsible for registering learners, delivering qualifications, and assessing learners against the qualifications. Approved centers must have assessors and internal quality assurers and can offer qualifications to learners within and outside their own organization.
Lk and pr introduction to qualificationMike Harris
This document provides information about a new level 3 Diploma for Health Screeners qualification for staff working in the NHS screening programmes. It outlines the mandatory units covering areas like infection control, safeguarding and health screening principles. Program-specific core units are also described for Diabetic Eye Screening, Abdominal Aortic Aneurysm Screening and Newborn Hearing Screening. The qualification aims to provide nationally recognized certification that staff have the required knowledge, skills and competencies to work in screening programmes. More details on the qualification can be found on the PHE Screening CPD website and blog.
2. feedback from qa visits – themes and findings so farMike Harris
The document discusses feedback from quality assurance visits to NHS screening programs, identifying several key themes in the programs' governance, operations, and quality management. Areas examined included guidelines, standard operating procedures, risk and incident management, fail-safes, escalation processes, auditing, data collection and ratification, and staff job descriptions and roles.
The document discusses key themes and findings from quality assurance visits to NHS screening programs including governance, guidelines and standard operating procedures, risk and incident management, failsafe processes, escalation procedures, auditing, data collection and ratification, and job descriptions and role structures.
NHS CSP Screening Quality Assurance Service update Mike Harris
This document provides an update on screening quality assurance. It introduces the regional structure for cervical screening quality assurance services in London and key personnel. It discusses the programme specific operating model, including the establishment of a quality assurance project group. It outlines the screening pathway that quality assurance covers. It also provides information on quality assurance visits, recommendations, incidents reporting, and root cause analysis.
NHS CSP document 20 updated version – March 2016Mike Harris
This document provides guidelines and standards for colposcopy services in the UK. It outlines referral guidelines for different cervical abnormalities, with 99% of women with inadequate samples, borderline changes or low-grade dyskaryosis being seen within 6 weeks, and 93% of women with high-grade dyskaryosis or suspected cancers being seen within 2 weeks. It describes quality standards for facilities, staffing, documentation, diagnosis, treatment and follow-up. All colposcopists must be certified and see a minimum caseload annually. Multidisciplinary team meetings should occur monthly to discuss difficult cases. The guidelines aim to ensure colposcopy services meet high standards for patient care, safety and outcomes.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...rightmanforbloodline
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - 34.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
Get Covid Testing at Fit to Fly PCR TestNX Healthcare
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Hypertension and it's role of physiotherapy in it.Vishal kr Thakur
This particular slides consist of- what is hypertension,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is summary of hypertension -
Hypertension, also known as high blood pressure, is a serious medical condition that occurs when blood pressure in the body's arteries is consistently too high. Blood pressure is the force of blood pushing against the walls of blood vessels as the heart pumps it. Hypertension can increase the risk of heart disease, brain disease, kidney disease, and premature death.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
MYASTHENIA GRAVIS POWER POINT PRESENTATIONblessyjannu21
Myasthenia gravis is a neurological disease. It affects the grave muscles in our body. Myasthenia gravis affects how the nerves communicate with the muscles. Drooping eyelids and/or double vision are often the first noticeable sign. It is involving the muscles controlling the eyes movement, facial expression, chewing and swallowing. It also effects the muscles neck and lip movement and respiration.
It is a neuromuscular disease characterized by abnormal weakness of voluntary muscles that improved with rest and the administration of anti-cholinesterase drugs.
The person may find difficult to stand, lift objects and speak or swallow. Medications and surgery can help the patient to relieve the symptoms of this lifelong illness.
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
2. Part of Public Health England
Abdominal Aortic Aneurysm
NHSAAAScreening Programme
Network meeting
June 2016
Jonothan JEarnshaw
Clinical Lead
3. Results
• 1.3 million men invited
• 1,019,480 men screened (uptake 79.5%)
• Almost 13,000 AAA (>3cm) detected
• Prevalence 1.3%
•Almost 12,000 men in surveillance
• Some 1923 men referred for surgery
results available https://www.gov.uk/topic/population-
screening-programmes/abdominal-aortic-aneurysm
4. LargeAAA(>5.4cm) detected
1025 65-year-old men first scan
898 men from surveillance
49% EVAR
51% Open repair (OR)
(3:1 EVAR:OR rate in UK overall)
Intervention rate around 91%
Mortality rate 0.9%
5. Update on Programme optimisation:
Health ImprovementAnalyticalTeam, Department of
Health
• Reducing surveillance
• Reinviting men with subaneurysmal aorta
• Inviting women
6. Surveillance intervals
Option A
2year, 3month
Option B
1year, 6month
Option C
2year, 6month
Option D
3year, 3month
Cost Savings per man invited
(£)
2.57 1.51 3.45 3.78
QALY Gain per man invited (£)⁺ -1.25 -1.41 -2.46 -3.28
Net Benefit per man invited (£) 1.33 0.10 0.99 0.50
Total Cost Saving from fewer
Screens per invited cohort (£)⁰
680,000 480,000 1,110,000 960,000
Fewer Scans per invited cohort 12,000 8,750 20,000 17,000
⁰ Total savings associated to invited cohort of 300,000, discounted at
3.5% per annum
⁺QALYs monetised at £20,000
7. Increasing detection ofAAA
Subaneurysmal aorta – 25 year data from Gloucestershire
0
.2.4.6
0 5 10 15 20 25
Time (years)
Initial Diameter: 2.6-2.9cm Initial Diameter: 3.0-5.4cm
with mortality as a competing outcome
Cumulative Incidence Function for Progression to 5.5cm
0
.2.4.6
CumulativeIncidence
0 5 10 15 20 25
Time (years)
<3cm+ 5 years after first scan 3cm+ 5 years after first scan
with mortality as a competing interest
Cumulative Incidence Function for Reaching 5.5cm+
8. Subaneurysmal aorta
>2.9cm % 0f 1156 >5.4cm % 0f 1156
Within 5 years 541 47% 7 0.6%
Within 10
years
659 57% 71 6%
Within 15
years
674 58% 138 12%
Within 20
years
674 58% 151 13%
Latest results from the Gloucestershire and Swindon AAA Screening
Programme (unpublished)
9.
10. Health ImprovementAnalytical Team
Recommendations:
Surveillance intervals for men with small AAAs should be extended so that
scans are performed biennially, as opposed to annually. This will lead to a more
cost-effective programme and 12,000 fewer rescans per invited cohort.
The NSC is asked to give careful consideration to the existing published
evidence relating to sub-aneurysmal aortic dilation. A rescan at 5 years would
require an additional 6,500 scans per invited cohort.
There is not currently enough evidence to justify the introduction of AAA
screening for women though this issue should be revisited in future years.
11. Optimising AAA screening
• Evidence review
• NAAASP Strategic and Research Groups
• NAAASP Directors, and other interested parties
• NAAASP Advisory Board
• Costing options DH Health Improvement Analytical Team
• 4 Nations Group (June 2015)
• Advice to obtain more independent evidence
• National Screening Committee (Oct 2016)
• Department of Health and Public Health England
• Implementation (2018/19)
16. Equality and diversity report
Jo Jacomelli
Conclusions:
• Uptake affected by social deprivation
• AAA prevalence affected by social deprivation
• Uptake affected by ethnicity – need to improve recording
• AAA prevalence may be affected by ethnicity (confounder is
relationship between ethnicity and deprivation)
19. NAAASP National Networking
and Information Day
Lisa Summers
NHSAAAScreening Programme Manager
June 2016
Public Health England leads the NHS Screening Programmes
20. 2016-17 Objectives
Review optimisation of AAA Screening Programme
Specify and re-procure national IT screening system to support existing
programme
Improve the dissemination of data to support local screening programmes,
commissioners and QA linking in programme specific operating model for
QA and inequalities reports for local programmes and commissioners
20 ISF UPDATE
25. Nurse Practitioner Group
• Develop, implement and monitor best practice guidelines
• Best practice guidelines to support AAA Nurse Specialist
• Develop and introduce nursing Standard Operating Procedures
25 ISF UPDATE
32. NAAASP research
• External to the Programme (Research Lead: Tim Lees)
• Programme research/evaluation
- Self referred men
- Prevalence monitoring
- Safety in surveillance
- National mortality rates
33. Approvals
Prehabilitation
Diet & AAA
Understanding non-attendance
Cardiovascular risk reduction –
feasability study
Drug study – reducing growth
Aardvark
Pre-operative exercise
Data to inform treatment risk algorithm
UKAGS
Metabonomic analysis serum & urine
Multimodal assessment of AAA
pathogenesis
Programme evaluation – growth rates
& surveillance data
37. Safety in surveillance
Total 12,804 men in surveillance
Follow-up 24,127 person years
Risk of rupture:
3-4.4cm (7 ruptures) – 0.03 (c.i. 0.02-0.07) per 100 person
years
4.5-5.4cm (8 ruptures) – 0.42 (c.i. 0.21-0.85) per 100
person years
44. Conclusion
NHS AAA Screening Programme is feasible and cost
effective.
Referral threshold safe
Still room for optimisation
On target to reduce deaths by up to 50%
47. Programme specific operating model
47 Data and reporting
Aim – To describe the activities of the Screening Quality Assurance Service
Data chapter
• Outlines the indicators used by SQAS for visits and ongoing
activities
• Cover key points in the screening pathway
• Information on sources, data sharing, reporting and data requests
https://www.tumblr.com/search/cute%20possums
48. PSOM indicators
National / retired standards
• Ineligible men
• Incorrect contact details
• Eligible men excluded
• Men with an aorta ≥ 3.0cm on initial screen
• Referrals deemed fit for intervention at first assessment post referral
• Operative procedures on AAA <5.5cm at last ultrasound
• 30 day mortality following elective surgery
• One year any cause mortality following elective surgery
• One year AAA cause mortality following elective surgery
48 Data and reporting
49. PSOM indicators
Invitation and attendance standards
• Men declining screening
• Men who DNA their first appointment
• Men who attend after not attending first appointment
• Men with an aorta 3.0 – 4.4cm on initial screen
• Men with an aorta 4.5 – 5.4cm on initial screen
• Men with an aorta ≥5.5cm on initial screen
Internal QA
• Percentage of scans sent for IQR
• Percentage of men recalled following internal QA
• Delay between scan and QA review
Surveillance men
• Percentage of men lost from surveillance by reason
49 Data and reporting
50. Process for PSOM data
• Collected from routine SMaRT data
• Produced quarterly on a programme level
• Draft report will be signed off by QA steering group
• Will be piloted with the SQAS (regions) to ensure it is fit for purpose and
obtain a baseline
• No thresholds initially
• Will be made available to programmes through SMaRT
50 Data and reporting
51. Inequalities report
• Available through SMaRT quarterly
• Tables of
• Eligible, offered, screened and declined by
• GP
• LSOA
• LA
• Ethnicity of men tested by
• Programme
• LA
• Ethnicity of men with aorta ≥3.0cm
• Line list of men referred for surgery by LSOA and ethnicity
51 Data and reporting
53. How can this information be used?
How do I know if I have a particular ethnic group not attending screening?
Sources of ethnicity data
• Office for national statistics
• NOMIS :
https://www.nomisweb.co.uk/query/construct/summary.asp?mode=constru
ct&version=0&dataset=651
• NOMIS uses 2011 census data – most up to date
You can create a table and chart comparing the breakdown of men you have
tested by ethnicity and the percentage of men in that ethnic group in the
population
53 Data and reporting
55. Scatter chart – national black or black
British: Caribbean
55 Data and reporting
56. Scatter chart – national black or black
British: Caribbean
56 Data and reporting
57. Deprivation
How do I know if men in particular areas aren’t attending?
Sources of information:
Office for national statistics:
http://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/
populationestimates/datalist
Link to IMD2015 by LSOA
https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015
Look at areas of low uptake and see if they are in areas of deprivation
57 Data and reporting
58. Can anyone help me with this?
Yes!
We will produce a template to help with the ethnicity comparison and
deprivation
Your commissioners can help with interpretation
Look at issues in your area in order to decide which interventions are the most
suitable
58 Data and reporting
59. 8 week waiting time – 2014/15
Breakdown of men referred to and not declining surgery by outcome for the 8
week to treatment standard, by programme
59 Data and reporting
60. 8 week waiting time – Q1 to Q3 2015/16
Breakdown of men referred to and not declining surgery by outcome for the 8
week to treatment standard, by programme
60 Data and reporting
61. Improvements
2014/15 Q1-Q3 2015/16
England % men
operated on in 8 weeks
56.9% 75.5%
England % breach -
patient comorbidity
24.8% 12.8%
England % breach -
hospital factors
18.3% 11.7%
Number of programmes
reaching acceptable
16 14
Number of programmes
reaching achievable
5 19
61 Data and reporting
63. Managing and learning from
incidents in the AAA screening
programme
JaneWoodland: Regional HeadofQualityAssurance,MidlandsandEast
28June2016
Public Health England leads the NHS Screening Programmes
64. • Why this is important
• What we like you to know and do
• Examples for discussion
65. Why this is important
• Ethical duty
• Statutory requirement
Mid Staffs
Duty of candour
• Improve quality and safety of screening programmes –
locally and nationally
65
Managing Safety Incidents in NHS Screening Programmes
66. Learning from incidents
66
Managing Safety Incidents in NHS Screening Programmes
National learning
• The 2015-16 national service spec was updated to reflect programme
responsibility to track referrals
• All screen positive AAA referrals are tracked using the SMaRT referral
tracking application which was installed as part of release 9 software
upgrade in July 2015
• The national programme checks AAA death proformas and ensures that a
copy is sent to QA if not already done so
• National “blogs” and previous newsletter articles, and enquiries made to
programmes via QA teams
• Refining the process for dealing with queries/incidents involving the national
software
……huge learning and a safer service for patients
68. The Policy framework
Managing Safety Incidents in NHS Screening Programmes
(MSI in NSP)
https://www.gov.uk/government/publications/managing-safety-incidents-in-
nhs-screening-programmes
(October 2015)
NHS England Serious Incident Framework (SIF)
https://www.england.nhs.uk/patientsafety/serious-incident
(March 2015)
68 Managing Safety Incidents in NHS Screening Programmes
69. Screening safety incident
Screening safety incidents include:
• any unintended or unexpected incident(s), acts of commission or acts of
omission that occur in the delivery of an NHS screening programme that
could have or did lead to harm to one or more persons participating in the
screening programme, or to staff working in the screening programme
• harm or a risk of harm because one or more persons eligible for screening
are not offered screening.
Refer to: Section 1.5 ‘Definition of a screening safety incident’ Managing
Safety Incidents in NHS Screening Programmes
69 Managing Safety Incidents in NHS Screening Programmes
70. 70 Managing Safety Incidents in NHS Screening Programmes
• Serious incidents in
screening programmes
have consequences that
are so significant that
they require a heightened
response
• Avoidable severe harm or
death if situation
continues
• Case by case judgement
and expert advice needed
Serious incidents in NHS screening
programmes
71. Serious incidents in screening programmes
Organisation unable to deliver acceptable quality of healthcare services
Examples include
Serious data loss/information governance related incident
Where the potential for harm may extend to a large population
Systematic failure to provide an acceptable standard of safe care
Major loss of confidence in the service including prolonged adverse media
coverage or public concern about the quality of healthcare or the
organisation
0eRefer to: Section 1.6 ‘Definition of a serious incident ’ Managing Safety Incidents in NHS
Screening Programmes
71 Managing Safety Incidents in NHS Screening Programmes
72. 72 Managing Safety Incidents in NHS Screening Programmes
Providers
SIT /
responsible
commissioner
PHE QA
Accountability, roles &
responsibilities
73. What we’d like you to do
Reporting, management and investigation
74. Screening incident assessment form
The screening incident assessment form (SIAF) is to be used for suspected
safety incidents and serious incidents in NHS screening programmes.
The form should be accessed from the DH.gov.uk website at
https://www.gov.uk/government/publications/managing-safety-incidents-in-nhs-
screening-programmes
74 Managing Safety Incidents in NHS Screening Programmes
75. 75 Managing Safety Incidents in NHS Screening Programmes
Safety incident
suspected
Provider informs
QA & SIT
Fact Finding
Classification and
handling plan in 5
working days
Serious incident
declared
Reported on
STEIS within
48hours
Serious incident
team
Serious Incident
team reports level
of investigation
within 72 hrs
SI Report
including incident
chronology and
RCA &
recommendations
QA disseminates
lessons identified
Screening incidents –Actions
77. 77 Managing Safety Incidents in NHS Screening Programmes
Data Gathering
Analysis
Solution
What’s happened?
Investigation
Why did it happen?
Determine root cause
What should we do to prevent
it happening again?
Implement corrective actions
Adapted from CPA Standard H6.2
78. Safety Incident reports by SIAF classification
Safety incidents for internal investigation – no further QA action –
• Provider decides format in line with its governance process
• Screening and immunisation team may want to review
• Recorded on SQAS and SIT monitoring systems
Safety incidents internal investigation and RCA
• QA advise that a one page report is produced – suggested template
available
• SIAF included as an appendix
Safety incident (multi-organisation/disciplinary, investigation panel and
RCA
• QA advise that NPSA concise report with SIAF included as an appendix
78 Managing Safety Incidents in NHS Screening Programmes
80. Scenarios for discussion
Is this a -
• safety incident
• a serious incident
• not an incident
What immediate actions would you take?
80 Managing Safety Incidents in NHS screening Programmes
Activity
81. Categories
81 Managing Safety Incidents in NHS Screening Programmes
Not an incident
Screening safety incident
Serious incident
82. Questions – Slide 1 (10minstodiscuss)
82
Managing Safety Incidents in NHS Screening Programmes
Scenarios around 8 week breaches
1 Patient cancelled surgery date which was offered within 8 weeks (due to
his daughters wedding), and then AAA ruptured before next offered
surgery date.
2 Stent was not available within 12 weeks and patient’s AAA ruptured
3 Surgery cancelled due to ITU bed availability. Surgery re-scheduled for
after 12 weeks. Patient AAA ruptured in the interim but patient recovered
well from emergency surgery.
4 Surgery scheduled outside of 12 weeks due to shortage in interventional
radiologists. Patient died of a AAA rupture before surgery date.
5 AAA repair conducted successfully. Patient died post operative within 30
days.
83. Questions – Slide 2 (10minstodiscuss)
83
Managing Safety Incidents in NHS Screening Programmes
Scenarios within the screening pathway
1 Images saved to incorrect patient file
2 Images lost during upload to SMaRT
3 Patient appointments cancelled due to staff sickness on day of
clinic
4 Scanner stolen from technician’s front seat of car after a busy
clinic day
5 Last weeks 2nd DNA letters to GP did not generate and SMaRT
shows an error
6 A number of surveillance patients were not being routinely
called to 3 monthly surveillance appointments over an annual
period.
86. Self referral to the NHS
Abdominal Aortic
Aneurysm Screening
Programme
Lewis Meecham, Jo Jacomelli,
Arun D. Pherwani, Jonothan Earnshaw
87. Introduction & Aims
• NHS abdominal aortic aneurysm screening programme
introduced in England 2009
• Fully operational since 2013
• All men are invited for screening in 65th year
• Men aged more than 65 years are allowed to self –refer for
screening
• Currently screening approximately 300, 000 men per annum
• The aim was to provide a descriptive analysis of men who self
refer to the NAAASP from 2009 toAugust 2014
88. Demographics
• 2009 to Aug 2014
• 58,999 self referrals (700,816 invited in same time period)
• Mean age 73 years (range 47-100).
• 82% with smoking history
• Incidence of AAA was 4.13% (n = 2,438), in contrast to
1.4% in the invited cohort (age 65)
• Of these 7.6% (n=186) were 5.5cm or greater.
Small AAA (3-
4.5cm)
Large AAA
(5.5cm and
greater)
PValue
Aspirin 41.7% 43.0% 0.416
Statin 64.9% 61.3% 0.681
90. Results
Type of
surgery
N Percentage
Open 39 38.8%
EVAR 84 55.3%
Outcome Percentage
Surgery 81.7% (n=152)
Declined 5.4% (n= 10)
Unfit 4.8% (n = 9)
Died in referral
pathway
1% (n=2)
30 day operative mortality – 0%
8Week referral to surgery target –(n = 88) (57.9%)
Mean time from referral to surgery was 69 days (2 – 361 days)
91. Discussion
• NAAASP 65 currently 1.4% 1
• MASS trial incidence 4% (screen age 65-74)2
• US veterans affairs incidence 7% (mean age 72)3
• We found in self referrals an incidence of 4.13% likely due
to (age (73 years), smoking (82%), ethnicity (96% white),
low compliance with BMT)
• Self referral element is cost effective
• Role of future publicity from local / natinal programme
1. http://aaa.screening.nhs.uk/news.php?monthye=0713
2. Thompson SG, et al. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the
randomised Multicentre Aneurysm Screening Study. BMJ 2009;38:2307
3. Chun KC, et al. Risk factors associated with the diagnosis of abdominal aortic aneurysm in patients screened at a regional
Veterans Affairs health care system. Ann Vasc Surg. 2014 Jan;28(1):87-92.
92. Conclusion
• Self-referral has yielded higher detection rates than the invited
cohort, more than justifying its cost.
• Now that NAAASP is fully operational it is important to
continue media campaigns and publicity to target the high risk
men over 65 who would otherwise miss the benefits of AAA
screening.
• Self referrals increased with increased publicity – could this be
channeled to target more at risk individuals
• Publicity should be targetted to high risk individuals
93. UKAGS and Research on Screening Women
Matt Bown
University of Leicester
www.le.ac.uk
100. SWAN
• NIHR HTA commissioned project
• Project team
– Simon Thompson (PI)
– Mike Sweeting
– Janet Powell
– Edmund Jones
– Pinar Ulug
– Matt Glover
– Jonothan Michaels
– David Sidloff
102. SWAN: Methods
• New programmable statistical/economic model
• Wide range of parameters required
• Data sources
– Literature
– Databases (NVR, HES-ONS, Vascunet)
– Male (screening) data
103. SWAN: Outputs
• New model
• Estimate of clinical effectiveness
• Economic analysis
• Value of information
104. FAST
• NIHR RfPB (researcher led)
• Pilot of AAA screening for women
• Leicestershire, Rutland and Northamptonshire
105. FAST: Methods
• GP read codes used to identify cohorts at GP practices
– Smoking (current or ex)
– History of coronary heart disease (MI, PCI, CABG)
– Ethnicity
– Healthy (non-smokers and no CHD)
– First-degree relatives of patients with AAA
• 65 to 74 year-old women
106. FAST: Methods
• GP read codes used to identify cohorts at GP practices
– Smoking (current or ex)
– History of coronary heart disease (MI, PCI, CABG)
– Ethnicity
– Healthy (non-smokers and no CHD)
– First-degree relatives of patients with AAA
• 65 to 74 year-old women
107. FAST: Methods
• NAAASP type invitation
• Consent at clinic for screening
• Consent for research at the same time as screening
• Data collection
– Screening outcomes
– Basic demographics/biometry
– QoL
– Linkage (GP, hospital, HES-ONS)
109. FAST: Sample size
n
• Smoking: Current smokers 2626
Ex-smokers 2626
• History of coronary heart disease 1700
• Ethnicity 1000
• Healthy (non-smokers and no CHD) 1000
• First-degree relatives of patients with AAA 1003
110. FAST: Outcome measures
• Primary
– Attendance
– Prevalence of AAA
• Secondary
– Accuracy of primary care read codes for AAA risk
– Long-term outcomes
111. FAST: Timeline
• Project start: 1st Aug 2016
• Screening start: 1st Nov 2016
• Project end: 31st Dec 2017
112. FAST: Timeline
• Project start: 1st Aug 2016
• Screening start: 1st Nov 2016
• Project end: 31st Dec 2017
113. FAST: Timeline (not so FAST)
• Original application: 16th Sept 2014
• Rejection: 23rd March 2015
• Revised application: 18th May 2015
• Acceptance: 26th Nov 2015
• Pre-project bureaucracy: 7 months!
• Project start: 1st Aug 2016
• Screening start: 1st Nov 2016
• Project end: 31st Dec 2017
115. NAAASP National Networking
and Information Day
Patrick Rankin
National education and training manager
Public Health England leads the NHS Screening Programmes
116. New qualification
• level 3 award on the regulated qualification framework (RQF)
• Level 3 is academic level not AfC
• Diploma for Health Screeners (DES/AAA/NBHS)
• provides clinical screening staff with a nationally recognised
qualification
• ensures clinical staff have the knowledge, skills and understanding
to work in a healthcare environment
• provides screening staff with a framework to develop knowledge
and clinical skills required for their specific screening programme
• opens up numerous career development opportunities for staff
within screening programmes
• can add additional screening programmes if required
Reaccrediation Update June 2016
117. Who needs to take the qualification….?
• from 1st April this is the required qualification for clinical staff in DES,
AAA and NBHS(2017)
• includes new all non-professionally regulated new clinical staff
• screening technicians in NAAASP
• previous qualification will remain valid and existing staff do not have
to undertake the diploma for health screeners
• can apply for recognition of prior learning
Reaccrediation Update June 2016
118. Structure of the qualification
• similar structure to NVQs
• work based qualification
• based on a number of units and evidencing work based
competency to an assessor
• assessors will need to have a qualification in assessing
• learners provide evidence of competency via local
assessments
• different method of delivery from current course
Reaccrediation Update June 2016
119. Mandatory units (13)
• provides screening programme staff with the basic understanding
and core knowledge and skills of working in a healthcare setting
• formalisation of learning that should already undertaken in
screening programmes
• should be covered in employee induction
• based on significantly on the care certificate
• provides confidence that all staff have the same induction - learning
the same skills, principles, knowledge and behaviours to provide
compassionate, safe and high quality health care
• resources available online that cover the majority of the learning
outcomes required for the mandatory units
• skills for care and skills for health websites have lots for
resources……..
Reaccrediation Update June 2016
120. Mandatory units
• Engage in personal development in health, social care or children’s and young people’s settings
• Promote communication in health, social care or children’s and young people’s settings
• Promote equality and inclusion in health, social care or children’s and young people’s settings
• Promote and implement health and safety in health and social care
• Principles of safeguarding and protection in health and social care
• Promote person centred approaches in health and social care
• The role of the health and social care worker
• Promote good practice in handling information in health and social care settings
• The principles of Infection Prevention and Control
• Causes and Spread of Infection
• Cleaning, Decontamination and Waste Management
• Principles for implementing duty of care in health, social care or children’s and young people’s
settings
• Health Screening Principles
Reaccrediation Update June 2016
122. Core units
• 3 core units for AAA
• similar content and level to the previous qualification
• updated and combined
• based on feedback and survey from learners who have
undertaken the previous qualification
• allows local programmes to tailor the learning and
assessment for each individual learner
• Undertake role specific units………..
Reaccrediation Update June 2016
123. Core unitsAAA
• Principles of AAA screening and treatment
• Principles of ultrasound for AAA screening
• Undertake AAA screening
• All staff that undertake screening within NAAASP need to undertake the
qualification
Reaccrediation Update June 2016
124. Unit structure
• each unit has a number of learning outcomes
• these are statements that describe the essential learning that learners need to be
able to clearly demonstrate at the end of the unit
• Syllabus
• the learning outcomes can then be broken down into assessment criteria
• these list in further detail the content that the learner must be able to demonstrate
during assessment of the unit
• should be used to guide the learners in their study and as to what needs to be
covered
• the assessors will then also receive the indicative content
• this details what the learner must cover in their assessment of the unit
• learners must not see the indicative content
learning outcomes assessment criteria indicative content
Reaccrediation Update June 2016
126. Principles ofAAAScreening and Treatment
1. Understand the circulatory system
2. Understand the medical terms relevant to Abdominal Aortic Aneurysm
Screening
3. Understand the pathophysiology and formation of arterial disease
4. Understand the treatment options for Abdominal Aortic Aneurysms
• 30 hours minimum
• An elearning package exists for this unit
• Significant supplemental learning will be required
• Use internal resources and supplement learning
• CST/assessor should have oversight of this
Reaccrediation Update June 2016
127. Principles of ultrasound forAbdominal
AorticAneurysm Screening
1. Understand the theory of diagnostic B-mode ultrasound
2. Understand the main functions of ultrasound equipment controls
3. Understand ultrasound safety and the potential biological effects
• Minimum 40 hours total learning hours
• Elearning package to compliment
• Significant supplemental learning required
• Oversight from CST/assessor
Reaccrediation Update June 2016
128. UndertakeAAAScreening
1. Be able to minimise risk of injury within the health screening setting
2. Be able to assess the environment and equipment for an Abdominal Aortic
Aneurysm screening episode
3. Be able to prepare the individual for an Abdominal Aortic Aneurysm
screening episode
4. Be able to use an ultrasound transducer to acquire diagnostic images of the
abdominal aorta
5. Be able to manipulate the ultrasound equipment controls to optimise images
6. Be able to accurately save, record and store results of the screening event
7. Be able to follow agreed protocols following the screening event to
determine the appropriate course of action
Reaccrediation Update June 2016
129. • Practical unit
• Portfolio of experience on the CDP screening website
• Similar to previous portfolio
• Same competency levels
• Gateway one and two replaced with stage one and stage two
• Internal clinical assessments for each stage by CST
• External clinical assessment replaces the OSCE at Salford
• Internal and external CST complete the assessment
• 4 individuals (2 minimum to be aneurysmal)
• 300 hours of work based learning
Reaccrediation Update June 2016
131. Assessors
• OFQUAL and Skills for Health requirement that there must be suitable
trained workplace assessors for this qualification
• level 3 Certificate in assessing vocation achievement (CAVA)
• City and Guilds assessors without the CAVA qualification or equivalent will
need to undertake it
• PHE Screening and NOCN have developed a streamlined process at a
significantly reduced price
• work based distance learning/3 months to undertake
• recognition for prior learning and assessing
• completion of log book outlining previous experience
• final professional discussion with an external assessor
• Will provide assessors with nationally recognised assessor qualification,
role enhancement and CPD
• 1-3 per local programme
Reaccrediation Update June 2016
132. Assessment methods
• feedback from programmes and learners was the assessment requirements
were too rigid
• now local programmes can tailor the assessments they use to the individual
learners
• will be quality assured by the awarding centre to ensure appropriateness of
assessments
• can use existing resources and assessments
Assessment methods
portfolio of evidence logbooks on-line tests
clinical assessments elearning assignments
case studies reflective practice short notes
course attendance one:one discussions recorded discussions
existing in-house resources
Reaccrediation Update June 2016
133. Technicians as assessors
• Existing screening technicians can train to become assessors within their
departments
• Undertake the CAVA qualification locally
• Can assess parts of the qualification
• Must be occupationally competent in the learning outcome
• Funded by local screening programme
• Will need to be putting a new technician through the qualification whilst
undertaking the CAVA
• CAVA must be sourced and undertaken locally
• Liaise with Trust’s Learning and Development departments regarding the
CAVA initially
Reaccrediation Update June 2016
134. Funding
• Health Education England are funding the qualification
for 2016/17
• PHE Screening are administering it centrally
• only for new clinical staff within local programmes
• cost varies between awarding centres
• £800-1000/learner
Reaccrediation Update June 2016
135. How to register a new learner……
Reaccrediation Update June 2016
137. Nurse Specialist Best Practice Guidance
Background
• Role of the nurse has been varied across the country since inception
• The nurse specialist is an important role in the NHS abdominal aortic
aneurysm screening programme
• The role of the nurse practitioner/vascular nurse is to assess men and give
them appropriate advice on lifestyle changes
• They can also refer men on to other specialists and services, such as
smoking cessation.
• Links with other departments within the Trust to support these men
• All men found to have a small (3.0-4.4cm) or medium (4.5-5.4cm) aneurysm
are offered an appointment with their local programme’s nurse specialist
• Requirement for appointment within 12 months/3 months
• Phone appointments!!!
Reaccrediation Update June 2016
138. New guidance
• Developed following consultation with nurse specialists, programme co-
ordinators, directors
• Programmes had been asking for further guidance and support
• 18 months to develop
• a document that encompasses the best practice guidelines for those nurses
undertaking the role of nurse specialist within a local provider of NAAASP
• Endorsed by Society For Vascular Nurses as best practice
• SQAS to use to benchmark Nurse Specialist service within local
programmes
• Not mandated via programme standards or service specification
Reaccrediation Update June 2016
139. Contents
• Background and training of nurse specialists
• Staffing requirements
• Roles and responsibilities within the programme
• Clinic locations
• Timeliness of the nurse assessment
• What the nurse assessment should include
• Importance of face to face assessments
• Role of Screening technicians in nurse assessment
Reaccrediation Update June 2016
140. Background and Training
• Registered general nurse
• 3 years post registration experience
• Appropriate knowledge of the management of vascular disease (AAA)
• Job description for their role including clinical accountability
• Links with other key clinicians within the programme
• Knowledge of the screening programme
• NAAASP don’t provide specific training
• Working towards the SVN ‘Advanced Nurse Competency’s’
Reaccrediation Update June 2016
141. Staffing requirements
• 0.1 WTE as a minimum
• Highly recommend this time is ring-fenced
• Attend appropriate meetings of the screening programme and MDTs
• Provide training and support to screening technicians where appropriate
• Regular contact with the programme co-ordinator and director
Reaccrediation Update June 2016
142. Roles and responsibilities
• Ensure all men have opportunity to attend face to face
• Provide support, advice, secondary prevention and referrals if appropriate
to screen positive men
• Use SMaRT system to record patient contact
• Attend training where appropriate
• Cannot screen unless they have completed the required training
• Cannot sign of screening technicians as competent or perform IQA of scans
unless they possess a post graduate degree in medical ultrasound
Reaccrediation Update June 2016
143. Operational requirements
• Face to face appointment within 12 weeks
• Telephone consultation with those that can’t or won’t
• Reason for decline to be added to patient record
• Once they reach 4.5cm additional appointment to be offered
• Administrator should be utilised to book and contact patients
• Additional appointments can be given if requested
• 30 minute time slot for each appointment
Reaccrediation Update June 2016
144. Assessment
• Measure and record weight and height
• BMI
• Smoking status
• Resting BP
• Review current medication
• Diet, exercise and alcohol consumption if appropriate
Reaccrediation Update June 2016
145. Assessment advice
• Explanation of condition and brief overview of possible treatment options
• Surveillance programme and clinical preference
• Optimisation of BP
• Smoking cessation advice
• Determine and discuss any potential interventions required by GP
• Appropriate lifestyle advise in line with NICE guidelines
• Addressing emotional issues
• Discuss contact with DVLA
• Discuss familial risks with AAA
• SMaRT letter to GP and patient
Reaccrediation Update June 2016
146. • Following detection of an aneurysm technicians should actively encourage
men to attend
• Technicians should not be undertaking physiological measurements under
the auspices of working as a screening technician within NAAASP
• Not included in their scope of practice
• Appropriate training, QA, competencies would be requires if NAAASP was
to introduce this role enhancement
• Not recommended from NAAASP
Reaccrediation Update June 2016
147. More details
• PHE Screening CPD website
http://cpd.screening.nhs.uk/cms.php?folder=5165
• PHE Screening blog
https://phescreening.blog.gov.uk/
• PHE Screening helpdesk
PHE.screeninghelpdesk@nhs.net
Reaccrediation Update June 2016
148. CST training
• role of CST is integral to NAAASP
• improving the integration over the last 2 year into the programme
• updated the training of CST’s from May 2016 following discussions with
vascular scientists, CST’s and screening technicians
• training can now all be undertaken locally
• 7 elearning units
• 0.5 days shadowing an existing CST in clinic
• SMaRT/data session with co-ordinator
• assessor qualification (if appropriate)
• sign off from programme director
• must maintain their appropriate registration/accreditation with appropriate
bodies
• Do not have to attend for reaccreditation
Reaccrediation Update June 2016
149. Screening technician reaccreditation
• Reaccreditation process updated April 2016
• More robust framework to help strengthen technician understanding of the
core principles of their roles
• Now consists of two sections
• Knowledge assessment
• Scanning assessment
• Knowledge assessment
• Two elearning modules
• Must be completed before they can register for scanning assessment
• Pass mark of 90%
• Scanning assessment
• Two scans to NAAASP requirements
• Recovery portfolio if unsuccessful
• Reaccreditation every two years
Reaccrediation Update June 2016
150. Feedback from external QAvisits
MarkGannon,VascularConsultant,AAAScreening,HeartofEnglandNHSFoundation
Trust
KimKavanagh,AAAScreeningCoordinator,HeartofEnglandNHSFoundationTrust
PhilippaCastell,SeniorQAAdvisor,PublicHealthEngland
151. AAA QA Visits
Process tips and outcomes
Public Health England leads the NHS Screening Programmes
152. Visit in a nutshell
6 months - date agreed
- documentation sent for completion (contacts list, room
booking requirements and pre-visit questionnaire)
2 ½ months - return completed questionnaire to QA team
Day of visit - relax!
4-6 weeks post visit - factual accuracy comments required
8 weeks post visit – final report issued –start action plan
12 weeks post report published – exec summary published
Every quarter – progress against action plan required
12 months post visit – completed action plan requested
153 AAA QA visits tips and outcomes
153. Process tips
• Use your QA advisors – they are there to help and support you
• Don’t be afraid to ask questions or ask for clarification
• Let your QA advisor know if there is something you are anxious about or
feel should be included as part of your visit
• Answer the questions in the pre-visit questionnaire as fully as possible and
wherever possible provide evidence (or state evidence can be provided if
required)
• Label and reference your evidence logically
• Don’t be worried about recommendations– we aren’t going to ask you to do
something for the sake of doing it
• Use the process to foster engagement with your wider team and to highlight
the good work you are doing or where you need support with you executive
level team and commissioning team
154 AAA QA visits tips and outcomes
154. Process tips
6 months – date agreed and documentation sent to you so ideal time to think
about…….
Who is going to be the lead for the visit (usually falls to programme co-
ordinator)
Letting everyone know about the visit date – make sure those required for
interview will be available
How you will complete the pre-visit questionnaire – who will do what sections,
who will co-ordinate?
What venue will you use for the day, how many rooms can you book in
advance, can you provide lunch?
Post visit – establish task and finish group for producing action plan
155 AAA QA visits tips and outcomes
155. Recommendation themes
Staffing – organisational diagrams, job descriptions and wte, regular systematic
feedback on screener performance and quality of images, training,
attendance at team meetings
SOPs – document key work areas and appropriate formatting (version control,
review dates and sign off)
Risks – risks on programme register, clear governance and escalation
processes
Incidents – policy in line with national incident guidance, reporting of incidents
Treatment timelines - review of processes, monitoring, tracking and breach
reporting, actions identified and implemented
Non-visualisation – monitoring equipment and staffing against rates, timelines,
tracking and access of appointments
Audits – undertake DNA audits, audit NVR completion, share results and
actions from audits at boards
156 AAA QA visits tips and outcomes
156. Recommendation themes
157 AAA QA visits tips and outcomes
Programme board – quoracy, membership, participation, standard agenda
items, action logs, inclusion of compliments/complaints, user
representation,
Equipment - checks performed in line with NAAASP recommendations,
processes documented in a SOP, replacement plans, maintaining
competency on models, storage
Cohort information - review including information requests on transgender
males to females / translation / disability / mobility needs/additional support
when asking GPs for relevant information on their eligible cohort prior to
invitation, processes within prisons, home visits, risk assessments, user
surveys, requirement for early/late/weekend clinics
157. Shared learning themes
Technicians – involved in audits, increased understanding of functionalities with
ultrasound machines, attending theatre to observe EVAR procedures and
vascular clinics, training in British Sign Language, dementia training,
opportunity to observe and scan aneurysms being imaged in the main
vascular laboratory to ensure regular exposure, physiotherapy support, left
and right handed scanning techniques, protocol for return to work after
absence, CSTs running educational and interesting case reviews
Service improvement - improving access for men with learning disabilities,
detailed analysis of uptake rates/dna rates and targeted initiatives with
lower uptake GPs, engagement with homeless shelters, summary language
sheet to identify requirement for information in another language, project
with traveller community to promote GP registration, GPs review cohort
lists, electronic warning alert added to hospital Trust systems for all men
detected with an AAA , card provided to surveillance men to carry which
states they have a AAA, men routinely opted in to a smoking cessation
service
158 AAA QA visits tips and outcomes
158. Shared learning themes
Health Promotion - ongoing encouragement strategy and promotion/screening
at various venues – golf clubs, bowling clubs, football/rugby/cricket clubs,
rotary clubs, round table events, DIY stores (on discount days for 50+),
betting shops, supermarkets, libraries, keep fit classes
Policies/Processes - Detailed overarching operational policy for the entire
screening programme, referencing all policies, procedures and governance
arrangements in one document, trackers developed for ensuring robust
failsafe of patients through referral, surveillance, non-visualisation and
incidental findings and production of waiting times, streamlined same day
assessment clinic for pre-operative investigations, decline forms for opting
out of surveillance and non-visualisation appointments
Programme Board - effective working relationships between providers and
commissioners, service user attending and contributing to the programme
board
159 AAA QA visits tips and outcomes
159. Feedback
Feedback through our questionnaire link is currently limited – please complete
the link provided to you after a visit so that we can evaluate and review the
process.
Overall, has been noted as a positive experience, better than expected and
that good support is provided.
To note: review of pre-visit questionnaire is taking place
review of screener technician input into process is taking place
160 AAA QA visits tips and outcomes
160. Professional ClinicalAdvisor plea!
Being a PCA is really interesting, you learn a lot, is a great opportunity to
network and make friends, along with visiting a different part of the country
Opportunity for CPD – undertake national training
Plea for CSTs/QA Leads to become reviewers, please contact your QA advisor
if interested in becoming a PCA
161 AAA QA visits tips and outcomes